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Summary: Gel perrneation chromatography was used to fractionate zinc-bound constituents in haemolysates
of human blood samples. The zinc content of the fractions was determined by electrothermai atomic absorp-
tion spectrometry. The zinc-containing enzyme, carbonic anhydrase, was identified by isoelectric focusing. A
fraction of more than 0.9 of the zinc eluted from the column was bound to the carbonic anhydrase fraction.
The fraction of zinc associated with unbound carbonic anhydrase was 0.786 of the total, and the remainder
was found in a carbonic anhydrase-CO-haemoglobin complex.
Die Verteilung von Zink in menschlichen Erythrocyten
Zusammenfassung: Gelpermeations-Chromatographie wurde zur Fraktionierung von an Zink gebundenen
Bestandteilen in Hämolysaten von menschlichen Blutproben angewandt. Der Zinkgehalt der Fraktionen
wurde mit elektrothermaler Atomabsorptionsspektrometrie bestimmt. Das Zink enthaltende Enzym Car-
boanhydrase wurde durch isoelektrische Fokussierung identifiziert. Ein Anteil von über 0,9 des von der Säule
eluierten Zinks befand sich in der Carboanhydraser-Fraktion. Der Anteil des an freier Carboanhydrase asso-
ziierten Zinks betrug 0,786 von Gesamt-Zink, der Rest konnte einem Carboanhydrase-CO-Hämoglobin-
komplex zugeordnet werden.
Imttroduction
Evidence that carbonic anhydrase, the most abünd-
ant protein after haemoglobin in the erythrocytes,
contained zinc was provided by Keilin & Mann (1) in
1940. Funakoshi & Deutsch (2), using immuno-
chemical techniques, were able to confirm this find-
ing but in addition they reported that a small fraction
of zinc was bound to the copper-containing protein,
Superoxide dismutase, called cytocuprein by the au-
thors. More recently (3), it has been reported that
J. Clin. Chem. Clin. Biochem. / Vol. 22, 1984 / No. 2
human erythrocytes contain zinc protoporphyrin in
cases of lead poisoning and iron deficiency.
Most of the reported studies on the isolation of zinc-
containing constituents in erythrocytes have in-
volved multi-step Separation procedures, and re-
quire large volumes of blood. In the present study,
we developed methods, requiring only small quanti-
ties of sample, for the fractionation, identification
and determination of zinc-bound constituents in hu-
man erythrocytes.
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Materials and Methods
Appara tus
The equipment used for the fractionation of the blood haemolys-
ates is described elsewhere (4).
The atomic absorption measurements were made with a Perkin-
Elmer Model 5000 spectrophotometer equipped with a Perkin-
Elmer HGA 400 heated graphite atomiser and a Perkin-Elmer
Model AS-1 autosampler. The atomic absorption Signals were re-
corded with a Perkin-Elmer Model 56 strip-chart recorder.
Isoelectric focusing of the column fractions was performed with a
LKB system made up of the 1804 Ampholine PAG plates (pH
3.5-9.5), Model 2117 Multiphor and Model 2103 power supply.
Reagents
The reagents for the fractionation procedure, and atomic absorp-
tion measurements are s previously described (4). The Solutions
used for electrofocusing are s recommended by the manfuacturer
(5).
Procedures
Purification of reagents and column
The procedures for cleaning the columns, gel, buffer and UV cell
were described in a previous publication (4).
Sample collection and preparation
Blood samples obtained by Standard venipuncture were trans-
ferred to individual 10 ml polyethylene tubes containing heparin.
After centrifugation of the samples at 1000 g for 15 min, the plas-
ma was transferred to other tubes, the buffy coat was carefully
pipetted from the top of the red blood cells, and the latter were
resuspended in an equal volume of 9 g · l"1 saline at 4 °C. Resus-
pended red cells were centrifuged at 1000 g for 10 min, supernat-
ant removed by aspiration, and the whole procedure repeated
twice more after additions of fresh saline. The washed blood cells
(100 μΐ) were lysed by diluting 20-fold with deionised water. Sam-
ples and haemolysates were stored at 4°C.
Chromatography of the haemolysates
Haemolysate (l ml) was applied to the top of the gel, and after
eluting about 170 ml of buffer at a flow rate of 40 ml · h"1, fifty
4.0ml fractions were collected in individual vials.
Determination of zinc
Standards (0-40 μg Zn · Γ1) were prepared in 0.1 mol · Γ1 Tris
acetate buffer. For the total zinc determination, haemolysates
were diluted 1:20 with 0.1 mol · l"1 HNO3. Standards (0-40 μg
Zn · Γ1) were prepared in the same concentration of HNO3. In-
strumental conditions for the analysis were s given in a previous
publication (4).
Carbonic anhydrase assay
The enzyme activity was determined by a modified method of
Mattenheimer & DeBruin (6). The following modifications were
made. A stock solution containing the Veronal/Veronal-Na buf-
fer and the indicator was prepared by adding 400 ml, 44 ml and
18 ml of the Solutions, respectively. The incubation medium was
made up of 1.3 ml buffer/indicator mixture and l ml peptone wa-
ter. For the determination of carbonic anhydrase activity in the
erythrocytes 20 μΐ of l: 100 diluted haemolysate were pipetted in-
to the incubation medium. A similar determination in the column
fractions required 100 μΐ of undiluted sample.
Enzyme Identification
The procedure used for the isoelectric focusing experiments was
s recommended by the manufacturer (5). Samples were applied
to the gel surface using the filter paper method, and Coomassie
Brillant Blue R 250 was used for staining the proteins.
Results and Discussion
The distribution of zinc, carbonic nhydrase catalytic
activity, and the UV profile at 280 nm of a human
blood haemolysate after gel permeation chromatog-
raphy, is shown in figure 1. There are three features
to note in the above figure. First, the zinc chromato-
gram shows two distinct peaks, A and B. Second, the
distribution of the carbonic anhydrase activity is sim-
ilar to that of zinc. Third, the peak observed in the
UV profile which is due to haemoglobiri appears at
the same position s peak B.
In order to establish the molecular masses of the two
zinc peaks, the column was calibrated with proteins
of known molecular masses. The position of peak A
was found to correspond to that of a constituent with
relative molecular mass of about 25000. Estimates
of the molecular mass of carbonic anhydrase given in
the literature (7) vary between 26000 and 32000. In
addition to the similarities in molecular mass be-
tween the reported values and that obtained by cali-
bration, the near coincidence f the cafbonic anhy-
drase activity and peak A clearly indicates the asso-
ciation of zinc in this regiqn with the enzyme. The
slight difference in the maxima of the carbonic anhy-
drase activity and zinc peaks is due to the difference
in the activity of the two major isozymes (I arid II).
Over 98% of the total protein content in erythro-
cytes is haemoglobin, because of this ovefwhelming
concentration, in relation to other proteins, it is pos-
sible that minor proteins may be non-specifically
bound or trapped by haemoglobin-molecules and
thus eluted together. However, Backman (8) has
presented evidence to show that there is indeed an
interaction between CO-haemoglobin (HbCO) and
carbonic anhydrase. Furthermore, this interaction
occurs between HbCO and one isozyme, carbonic
anhydrase II. If a carbonic anhydrase-HbCO com-
plex does exist then it will have a molecular mass of
about 100000. The position of a constituent with a
molecular mass of 100000 is indicated by the arrow
(fig. 1). The amount of zinc in this region is higher
than the blank values which is- an indication of a pos-
sible interaction.
A further examination of this association was carried
out by applying a l: 3 instead of a l: 20 dilution of a
haemolysate to the column. The separated fractions
from both regions A and B, together with a pure
sample of carbonic anhydrase, were sijbjected to
isoelectric focusing. As shown in figure 2, a carbonic
anhydrase band (marked with arrow) is present in all
fractions. Furthermore, the intensity of this band in-
creased from region B to A in a similar pattern to the
distributions of zinc and carbonic anhydrase activity.
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Fig. l. Chromatography of human erythrocyte haemolysate on a SephacryJ S-300 column, showing elution profiles of zinc (D), carbonic
anhydrase catalytic activity (O), and the u. v. absorbance at 280 nm (—). The samples were eluted with 0.1 mol · l"1 Tris-acetate
buffer, pH 7.4, at 4°C and a flow rate of 40 ml · h"1. The letters A and B denote areas of suspected zinc binding.
Fig. 2. Isoelectric focusing of proteins in the eluted fractions. The
letters A and B denote regions of suspected zinc binding,
similarly lettered äs in figure 1. The arrow shows the
prominent carbonic anhydrase band, and l and 2 are sam-
ples of pure carbonic anhydrase enzyme.
In addition to isoelectric focusing, fractions were an-
alysed for zine and copper. The distribution of zinc
and copper in these fractions is shown in figure 3.
The single arrow indicates the position of peak B and
the double airows the position of a constituent with
molecular mass of 100000. Although there is evi-
dence to suggest the existence of a carbonic anhy-
drase-HbCO complex with molecular mass of about
100000, the isoelectric focusing experiments clearly
show the presence of carbonic anhydrase in the re-
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Fig. 3. The distributions of copper (Q) and zinc (O). Before the
fractions were analysed for zinc they were diluted five-fold
with buffer. The single and double arrows denote areas in
the chromatogram corresponding to molecular mass of
64000 and 100000, respectively.
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gion containing the highest concentration of haemo-
globin ( = 64000). An explanation for this appar-
ent discrepancy is that in permeation chromatogra-
phy Separation is achieved not strictly according to
molecular mass but Stokes radius. It is therefore pos-
sible that the difference between the Stokes radius of
the complex and haemoglobin is small and hence the
two constituents cannot be resolved ori the column
used. The formation of dimers by the carbonic anhy-
drase could also explain the occurrence of this zinc
peak. However, no such formation has äs yet been
reported for human carbonic anhydrase (9).
Examination of previously published methods for
the isolation of carbonic anhydrase showed that the
first step in the procedures developed had involved
the removal of haemoglobin from the haemolysate.
Haemoglobin was either destroyed by denaturation
and precipitation with a mixturte of ethanol, water
and Chloroform, or separated by chromatography. In
the first case, the carbonic anhydrase-HbCO com-
plex was destroyed and in the second the fraction
containing the complex was discarded. The presence
of this complex was therefore not observed by pre-
vious workers for the above reasons. The results
presented here, together with the work of Backman
(8), does provide evidence of an association between
carbonic anhydrase and CO-haemoglobin.
In contrast to zinc, only one major copper peak is
present in human erythrocytes (fig. 3). The differ-
ence in the elution volume between the zinc associat-
ed with unbound carbonic anhydrase (peak A) and
the copper peak is about 14 ml. This copper-contain-
ing constituent was found to have a molecular mass
of about 30000. This value is in good agreement
with the literature value of 34000 obtained for the
zinc- and copper-containing enzyme erythrocuprein
or Cu2Zn2 Superoxide dismutase. According to Fu-
nakoshi & Deutsch (2) this enzyme accoünts for a
fraction of about 0.025 of the total zinc in erythro-
cytes. A fraction of more than 0.9 of the copper in
erythrocytes is associated with this enzyme. This
finding is in good agreement with the work of
Gärtner & Weser (10) who found that a fraction of
about 0.95 of the copper in erythrocytes was bound
to Cu2Zn2 Superoxide dismutase. In the study, no
clear association between zinc and Cu2Zn2 Superox-
ide dismutase was found because both enzymes were
not completely resolved by the fractionation proce-
dure. However, the fraction of zinc bound to this
fraction will certainly be less than 0.1 of the total
present in the erythrocytes, assuming that similar
amounts of zinc and copper are bound tö the en-
zyme.
From the foregoing discussion it can be deduced that
nearly all of the zinc in erythrocytes is bound to car-
bonic anhydrase. However, the zinc associated with
this enzyme can be divided into two parts i.e. zinc
associated with unbound carbonic anhydrase, and
that associated with carbonic anhytfrase bound to
CO-haemoglobin. In order to estimate the relative
amounts of zinc in these two fractions, blood haem-
olysates from ten healthy adults were examined
(tab. 1). It was found that a fraction of 0.786 ±
0.045 (mean ± l SD) of the zinc recovered from the
column was associated with unbound carbonic anhy-
drase and a fraction of 0.214 ± 0.045 was in the
form of the complex.
Tab. 1. Distribution of zinc in human blood haemolysates.
Subject
K. L.
B. A.
R. A.
R. O.
B.I.
G. U.
W.I.
K.E.
M. O.
G. A.
Mean
±1SD
n = 10
Zinc asso-
ciated with
bound
carbonic
anhydrase
(ng)
187.9
111.6
91.0
123.8
96.9
126.0
98.6
162.6
165.1
225.4
138.9
±44.7
Fraction
of total
zinc
recovered
0.245
0.196
0.152
0.203
0.188
0.220
0.150
0.282
0.232
0.268
0.214
± 0.045
Zinc asso-
ciated with
unbound
carbonic
anhydrase
(ng)
577.6
457.9
506.3
489.5
417.7
445.6
558.5
415.1
545.
616.1
502.6
±69.8
Fraction
of total
zinc
recovered
0.755
0.804
0.848
0.797
0.812
0.780
0.850
0.718
0.768
0.732
0.786
± 0.045
According to Backman (8) the difference in the abil·
ity of the two isozymes to bind HbCO is an indicä-
tion that they may have different physiological fimc-
tions. In fact, it has been observed that under certain
pathological conditions only one isozyme shows
quantitative changes (9). It is also possible that only
one of these isozymes is affected in the development
of zinc deficiency. Therefore the determiiiatiön of
the amount of both major isozymes in erythrocytes,
in additiön to using the methods developed here,
provides an better way of studying these changes.
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